Cargando…
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma
BACKGROUND: Truncated tissue factor (tTF) retargeted by NGR-peptides to aminopeptidase N (CD13) in tumor vasculature is effective in experimental tumor therapy. tTF-NGR induces tumor growth inhibition in a variety of human tumor xenografts of different histology. To improve on the therapeutic effica...
Autores principales: | Brand, Caroline, Greve, Burkhard, Bölling, Tobias, Eich, Hans T., Willich, Normann, Harrach, Saliha, Hintelmann, Heike, Lenz, Georg, Mesters, Rolf M., Kessler, Torsten, Schliemann, Christoph, Berdel, Wolfgang E., Schwöppe, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034830/ https://www.ncbi.nlm.nih.gov/pubmed/32084238 http://dx.doi.org/10.1371/journal.pone.0229271 |
Ejemplares similares
-
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction
por: Berdel, Andrew F., et al.
Publicado: (2021) -
Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature: Are Results Predictive for Humans?
por: Berdel, Wolfgang E., et al.
Publicado: (2020) -
Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction
por: Stucke-Ring, Janine, et al.
Publicado: (2016) -
NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor
por: Brand, Caroline, et al.
Publicado: (2016) -
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
por: Kessler, Torsten, et al.
Publicado: (2018)